Management Recommendations for Prostate Cancer During the COVID-19 Pandemic: A Systematic Review

Management Recommendations for Prostate Cancer During the COVID-19 Pandemic: A Systematic Review

IntroductionThe COVID-19 pandemic has delayed screening, diagnostic workup, and treatment in prostate cancer (PCa) patients. Our purpose was to review PCa screening, diagnostic workup, active surveillance (AS), radical prostatectomy (RP), radiotherapy (RT), androgen deprivation therapy (...

Full description

Bibliographic Details
Main Authors:	Alan de J. Martinez-Salas, Iñigo Navarro-Ruesga, Erick A. Rodenas-Gil, Jesus S. Muruato-Araiza, Aldo Jimenez-García, Irving Reyna-Blanco, Jorge G. Morales-Montor, Carlos Pacheco-Gahbler
Format:	Article
Language:	English
Published:	MDPI AG 2021-07-01
Series:	Société Internationale d’Urologie Journal
Subjects:	androgen receptor antagonists adjuvant chemotherapy prostatic neoplasms radiotherapy sars coronavirus
Online Access:	https://siuj.org/index.php/siuj/article/view/130/50

Similar Items

Recovery of hormone sensitivity after salvage brachytherapy for hormone refractory localized prostate cancer
by: Dan Smith, et al.
Published: (2010-06-01)

Systemic Therapies for Metastatic Castration-Resistant Prostate Cancer: An Updated Review
by: Koji Hatano, et al.
Published: (2023-10-01)

Expanding armamentarium in advanced prostate cancer management: are all novel antiandrogens the same?
by: Emre Yekedüz, et al.
Published: (2021-03-01)

Combined Long-Term Androgen Deprivation and Pelvic Radiotherapy in the Post-operative Management of Pathologically Defined High-Risk Prostate Cancer Patients: Results of the Prospective Phase II McGill 0913 Study
by: Michael Jonathan Kucharczyk, et al.
Published: (2020-03-01)

External radiotherapy for prostate cancer with or without androgen deprivation: Geneva, 1991 to 2004
by: R Miralbell, et al.
Published: (2009-09-01)

Salvage Radiotherapy Plus Androgen Deprivation Therapy for High-Risk Prostate Cancer with Biochemical Failure after High-Intensity Focused Ultrasound as Primary Treatment
by: Ying-Che Huang, et al.
Published: (2022-07-01)

Radiation therapy after radical prostatectomy: Implications for clinicians
by: Fernanda G Herrera, et al.
Published: (2016-05-01)

Hormonal status in patients with advanced prostatic cancer on the therapy with androgen blockade
by: Vojinov Saša, et al.
Published: (2011-01-01)

A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients
by: Yoshiyuki Miyazawa, et al.
Published: (2017-08-01)

Multidisciplinary Consensus on the Prevention and Treatment of Osteoporosis and Fragility Fractures in Patients with Prostate Cancer Receiving Androgen-Deprivation Therapy
by: Enrique Casado, et al.
Published: (2022-01-01)

Hypofractionated Postoperative Radiotherapy for Prostate Cancer: Is the Field Ready Yet?
by: Sean Mahase, et al.
Published: (2020-12-01)

Postoperative Radiotherapy of Prostate Cancer: Adjuvant versus Early Salvage
by: Daniel Wegener, et al.
Published: (2022-09-01)

Economical impact of orchiectomy for advanced prostate cancer
by: Paula Adriano A. P. de, et al.
Published: (2003-01-01)

Current Situation of Postoperative Adjuvant Chemoradiotherapy for Extrahepatic Cholangiocarcinoma
by: YANG Xiao, et al.
Published: (2023-01-01)

The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications
by: Juan A Ramos, et al.
Published: (2012-01-01)

Mechanisms of Androgen Receptor Agonist- and Antagonist-Mediated Cellular Senescence in Prostate Cancer
by: Miriam Kokal, et al.
Published: (2020-07-01)

Simulating androgen receptor selection in designer yeast
by: Haoran Zhang, et al.
Published: (2022-12-01)

Androgen deprivation therapy is associated with decreased second primary lung cancer risk in the United States veterans with prostate cancer
by: Kyungsuk Jung, et al.
Published: (2018-08-01)

Enzalutamide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A retrospective Korean multicenter study in a real-world setting
by: Seung Il Jung, et al.
Published: (2020-01-01)

Rethinking Undertreatment in Elderly Breast Cancer Patients
by: Melanie DW Seah, et al.
Published: (2009-04-01)

Androgen Receptor-Dependent Mechanisms Mediating Drug Resistance in Prostate Cancer
by: Marzieh Ehsani, et al.
Published: (2021-03-01)

Mapping of Recurrence Sites Following Adjuvant or Salvage Radiotherapy for Prostate Cancer Patients
by: Ana Gonzalez-Moya, et al.
Published: (2022-01-01)

Impact of androgen deprivation therapy on mortality of prostate cancer patients with COVID-19: a propensity score-based analysis
by: Mateus Bringel Oliveira Duarte, et al.
Published: (2021-11-01)

Progressive vision loss as the initial symptom of Prostate Cancer
by: Ernesto Davila-Legorreta, MD, et al.
Published: (2022-05-01)

Observation with or without late radiotherapy is equivalent to early radiotherapy in high-risk prostate cancer after radical prostatectomy: A SEER-Medicare analysis on trends, survival outcomes, and complications
by: Young Suk Kwon, et al.
Published: (2021-06-01)

Quality of life and results of total androgen blockade alone and with radiotherapy in the treatment of nonmetastatic prostate cancer
by: Milovanović Lela, et al.
Published: (2012-01-01)

Isolated recurrence of prostate cancer to the anterior urethra 5 years after radiation therapy
by: Shinnosuke Fujiwara, et al.
Published: (2022-01-01)

Distinct mechanisms mediating therapy-induced cellular senescence in prostate cancer
by: Julia Kallenbach, et al.
Published: (2022-12-01)

ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer
by: Alan Dal Pra, et al.
Published: (2023-07-01)

Feasibility study on pre or postoperative accelerated radiotherapy (POP-ART) in breast cancer patients
by: Hans Van Hulle, et al.
Published: (2020-10-01)

Postoperative elective pelvic nodal irradiation compared to prostate bed irradiation in locally advanced prostate cancer – a retrospective analysis of dose-escalated patients
by: Carola Link, et al.
Published: (2019-06-01)

The protein composition of exosomes released by prostate cancer cells is distinctly regulated by androgen receptor-antagonists and -agonist to stimulate growth of target cells
by: Golnaz Atri Roozbahani, et al.
Published: (2024-04-01)

Testosterone therapy in men with prostate cancer: literature review, clinical experience, and recommendations
by: Abraham Morgentaler, et al.
Published: (2015-04-01)

Can palliative radiotherapy influence prostate-specific antigen response in patients with castrate-resistant prostate cancer treated with systemic therapy (chemotherapy or abiraterone)?-a report of three cases
by: Mohan Hingorani, et al.
Published: (2015-03-01)

Androgen Receptor Gene Pathway Upregulation and Radiation Resistance in Oligometastatic Prostate Cancer
by: Helen Saxby, et al.
Published: (2022-04-01)

Oligometastatic Prostate Cancer: A Comparison between Multimodality Treatment vs. Androgen Deprivation Therapy Alone
by: Francesco A. Mistretta, et al.
Published: (2022-05-01)

Surveillance as a safe and effective option for treatment of stage I seminoma
by: Vasco Quaresma, et al.
Published: (2023-09-01)

Effect of Adjuvant Therapy on Oncologic Outcomes of Surgically Confirmed Stage I Uterine Carcinosarcoma: a Turkish Gynecologic Oncology Study
by: Günsu Kimyon Cömert, et al.
Published: (2019-07-01)

Impact of Adjuvant Chemoradiotherapy on Survival of Resected Pancreatic Adenocarcinoma Cancer: A Surveillance, Epidemiology and End Results (SEER) Analysis
by: Xiaomao Shi, et al.
Published: (2021-07-01)

Medullomyoblastoma treated with craniospinal radiation and adjuvant chemotherapy: Report of 4 cases and review of the literature
by: Rony Benson, et al.
Published: (2015-06-01)